We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

87:HKEXSwire Pacific Limited Class B Analysis

Data as of 2026-07-16 - not real-time

MYR 0.75

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: the 20‑day SMA sits below both the 50‑day and 200‑day SMAs, confirming a bearish alignment, while the MACD line remains under its signal line, reinforcing downside momentum. Momentum is weak as the RSI hovers in the mid‑30s, suggesting the stock is approaching oversold territory but not yet signaling a clear reversal. Volume has been on a decreasing trend, indicating waning trader interest, and the 30‑day volatility remains elevated, which could amplify price swings. Valuation metrics show a trailing PE well below the industry average and a price‑to‑book ratio under 0.5, pointing to a materially discounted valuation; the forward PE of under 4 further underscores upside potential if earnings improve. Fundamentals: revenue growth is modest at under 2% annually, margins are thin, and the company carries a high debt‑to‑equity ratio, limiting financial flexibility. Cash generation is positive but modest, and free cash flow is limited relative to debt obligations. The market cap is small and daily trading volume is low, raising liquidity concerns. Risk profile: low beta suggests limited correlation with broader market moves, yet the combination of high leverage, geographic diversification across emerging markets, and sector exposure to cyclical industrial demand adds layers of risk. Outlook: while the stock appears undervalued on a relative basis, the bearish technical setup and constrained financial position temper enthusiasm, making a cautious stance advisable at present.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish SMA crossover
  • MACD below signal line
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount to peers
  • forward PE indicating upside
  • potential earnings improvement reflected in forward EPS

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high leverage limiting long‑term flexibility
  • diversified but low‑margin business model
  • persistent sector and geographic exposure risks

Key Metrics & Analysis

Financial Health

Revenue Growth1.80%
Profit Margin0.46%
P/E Ratio18.6
ROE3.25%
ROA3.43%
Debt/Equity188.28
P/B Ratio0.5
Op. Cash FlowMYR71.4M
Free Cash FlowMYR23.1M
Industry P/E30.8

Technical Analysis

TrendBearish
RSI36.8
SupportMYR 0.75
ResistanceMYR 0.78
MA 20MYR 0.76
MA 50MYR 0.77
MA 200MYR 0.78
MACDBearish
VolumeDecreasing
Fear & Greed Index92.54

Valuation

Target PriceMYR 1.39
Upside/Downside86.58%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.21
Volatility17.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.